1. Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death
   Agnieszka Sliwinska et al, 2015, Toxicology in Vitro CrossRef
2. Cell penetrating peptide of sodium-iodide symporter effect on the I-131 radiotherapy on thyroid cancer
   Yi-Xiang Fan et al, 2017 CrossRef
3. Tyrosine kinase inhibitors target cancer stem cells in renal cell cancer
   ANNA M. CZARNECKA et al, 2016 CrossRef
4. Anti-proliferative effect of metformin on a feline injection site sarcoma cell line independent of Mtor inhibition
   J. Pierro et al, 2017, Research in Veterinary Science CrossRef
5. Localized multidrug co-delivery by injectable self-crosslinking hydrogel for synergistic combinational chemotherapy
   Mengmeng He et al, 2017, J. Mater. Chem. B CrossRef
6. Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
   Zahra Nozhat et al, 2018, DARU J Pharm Sci CrossRef
7. Novel application of metformin combined with targeted drugs on anticancer treatment
   Jun Deng et al, 2018, Cancer Sci CrossRef
8. Recent advances in precision medicine for the treatment of anaplastic thyroid cancer
   Silvia Martina Ferrari et al, 2019, Expert Review of Precision Medicine and Drug Development CrossRef
9. Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
   Xinqun Chai et al, 2015, Sci Rep CrossRef
10. Sorafenib in the treatment of thyroid cancer
    Silvia Martina Ferrari et al, 2015, Expert Review of Anticancer Therapy CrossRef
11. Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy
    Fangfang Wang et al, 2015, Leukemia Research CrossRef
12. Metformin and thyroid disease
    Xianghui Meng et al, 2017 CrossRef
13. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells
    Alessandra Pattarozzi et al, 2017, Stem Cell Res Ther CrossRef
14. Novel treatment options for anaplastic thyroid cancer
    Poupak Fallahi et al, 2017, Expert Review of Endocrinology & Metabolism CrossRef
15. Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses
    Gheysen Laetitia et al, 2020, Cells CrossRef
16. Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
    Agnieszka Karbownik et al, 2020, Pharmaceutics CrossRef
17. Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
    Sae Ishihara et al, 2019, Int J Oncol CrossRef
18. Sequence‑dependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action
    Abdulmajeed Bahman et al, 2018, Int J Mol Med CrossRef
19. Combined effects of octreotide and cisplatin on the proliferation of side population cells from anaplastic thyroid cancer cell lines
    Zhilan Li et al, 2018, Oncol Lett CrossRef
20. Metformin: current clinical applications in nondiabetic patients with cancer
    Kailin Chen et al, 2020, Aging CrossRef
21. null
    Gautham Chengizkhan et al, 2020 CrossRef
22. Recent advances in the management of anaplastic thyroid cancer
    Simone De Leo et al, 2020, Thyroid Res CrossRef
23. Molecular targets of tyrosine kinase inhibitors in thyroid cancer
    Poupak Fallahi et al, 2020, Seminars in Cancer Biology CrossRef
24. Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion
    Yang Yu et al, 2022, Endocrine CrossRef
25. Current Status of Targeted Therapy for Undifferentiated Thyroid Cancer
    守博 李, 2022, ACM CrossRef
26. The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
    Zhimin Tang et al, 2021, ACAMC CrossRef
27. Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
    Mirian Galliote Morale et al, 2022, Biomolecules CrossRef
28. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line
    Zahra Nozhat et al, 2022, ACAMC CrossRef
29. THERAPEUTIC USE OF METFORMIN IN THYROID CANCER
    Fatimah Haitham Fathi et al, 2022, MMSL CrossRef
30. Inhibition of Glycogen Metabolism Induces Reactive Oxygen Species-Dependent Cytotoxicity in Anaplastic Thyroid Cancer in Female Mice
    Cole D Davidson et al, 2022 CrossRef
31. Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
    Jiaqian Yuan et al, 2022, Cancers CrossRef
32. null
    Ifigenia Kostoglou-Athanassiou, 2023 CrossRef
33. The development and benefits of metformin in various diseases
    Ying Dong et al, 2023, Front. Med. CrossRef
34. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
    Alessia Greco et al, 2023, Front. Pharmacol. CrossRef
35. Metabolic Reprogramming in Thyroid Cancer
    Sang-Hyeon Ju et al, 2024, Endocrinol Metab CrossRef